tradingkey.logo

Tempus AI Inc

TEM
59.964USD
-3.546-5.58%
取引時間 ET15分遅れの株価
10.66B時価総額
損失額直近12ヶ月PER

Tempus AI Inc

59.964
-3.546-5.58%

詳細情報 Tempus AI Inc 企業名

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Incの企業情報

企業コードTEM
会社名Tempus AI Inc
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)
従業員数2400
証券種類Ordinary Share
決算期末May 30
本社所在地600 West Chicago Avenue
都市CHICAGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号60654
電話番号18335144187
ウェブサイトhttps://investors.tempus.com/
企業コードTEM
上場日May 30, 2025
最高経営責任者「CEO」Lefkofsky (Eric P)

Tempus AI Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
1.25K
-1997.00%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
752.09K
-135234.00%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
102.70K
-1322.00%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
14.71K
-1997.00%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
10.43K
-2447.00%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-17168.00%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
3.61K
-250.00%

収益内訳

会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
他の
62.65%
株主統計
株主統計
比率
Blue Media, LLC
10.49%
BK TL21 LLC
8.80%
Lefkofsky (Eric Paul)
6.77%
The Vanguard Group, Inc.
5.92%
Gray Media, LLC
5.36%
他の
62.65%
種類
株主統計
比率
Corporation
29.32%
Investment Advisor
28.46%
Investment Advisor/Hedge Fund
11.65%
Individual Investor
7.45%
Research Firm
5.38%
Hedge Fund
4.27%
Holding Company
3.13%
Venture Capital
0.91%
Bank and Trust
0.88%
他の
8.55%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
708
89.83M
51.96%
-1.45M
2025Q3
619
75.72M
43.81%
-4.20M
2025Q2
501
136.83M
81.41%
-3.18M
2025Q1
444
136.54M
81.24%
-3.30M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Blue Media, LLC
18.14M
10.49%
-7.69M
-29.78%
Aug 08, 2025
BK TL21 LLC
15.22M
8.8%
--
--
Mar 18, 2025
Lefkofsky (Eric Paul)
11.70M
6.77%
-16.83K
-0.14%
Nov 25, 2025
The Vanguard Group, Inc.
9.42M
5.45%
+1.70M
+22.05%
Sep 30, 2025
Gray Media, LLC
9.27M
5.36%
-133.25K
-1.42%
Aug 08, 2025
Baillie Gifford & Co.
9.69M
5.61%
-2.40M
-19.86%
Sep 30, 2025
Red Sky LLC
8.06M
4.66%
-1.44M
-15.13%
Sep 30, 2025
ARK Investment Management LLC
7.18M
4.15%
-246.00K
-3.31%
Sep 30, 2025
SoftBank Group Corp
5.41M
3.13%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.38M
3.11%
+2.26M
+72.19%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
ARK Genomic Revolution ETF
12.02%
ARK Innovation ETF
5.1%
Global X HealthTech ETF
4.22%
Franklin Genomic Advancements ETF
3.92%
Renaissance IPO ETF
3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
3.05%
AXS Green Alpha ETF
2.92%
ROBO Global Artificial Intelligence ETF
2.49%
First Trust Health Care Alphadex Fund
2.42%
Innovator IBD 50 Fund ETF
2.22%
詳細を見る
ARK Genomic Revolution ETF
比率12.02%
ARK Innovation ETF
比率5.1%
Global X HealthTech ETF
比率4.22%
Franklin Genomic Advancements ETF
比率3.92%
Renaissance IPO ETF
比率3.83%
KraneShares Artificial Intelligence and Tcnlgy ETF
比率3.05%
AXS Green Alpha ETF
比率2.92%
ROBO Global Artificial Intelligence ETF
比率2.49%
First Trust Health Care Alphadex Fund
比率2.42%
Innovator IBD 50 Fund ETF
比率2.22%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI